Recon Strategy
Contact

Insights

Fifteen+ years of
Healthcare thinking.

Several hundred perspectives on the questions facing payers, providers, biopharma, medtech, and digital health — plus our running read on the clinical literature. Start with our sharpest work, or filter to your world.

Sector
All
NEJM opinion

Is Anthem drawing a line in the sand on drug pricing?

  • Biopharma
The public debate on drug pricing has sharpened markedly over the past…

Read more